Replies to post #24496 on Biotech Values

[DewDiligence]

>But the Pharming deal seems like a long shot and might not put a floor on GTCB's price in the short term.<

Pharming is definitely interested in acquiring GTC; the question is: at what price? I don’t think GTC would sell for $1.00 or $1.50, but they might for $2+. JMHO, FWIW